GHISLAINE MAXWELL- OAP FDG ACCT.
For the Period 1/1112 to 1/31/12
Equity Summary
Beginning Ending Change Current Asset Categories
Asset Categories Market Value Market Value In Value Allocation
US Large Cap Equity 160.064.44 156,814.37 (3,250.07) 9585
Concentrated .3 Other Equity 0.00 5,051.04 5,051.04 3%
Total Value $160,064.44 $161,865.41 $1,800.97 98%
COMOIlf arid 6 Other Eqfitif
Current
Market Value/Cost Period Value
Market Value 161.865.41
Tax Cost 146.974.44
Unrealized Gain;Loss 14990.97 *US Lap Cep EcitNty
Estimated Annual Income 5,407.27
Accrued Dividends 405.99
Yield 3.34%
Equity as a percentage of your portfolio - 98 %
Note- P indicates position adjusted for Pending Trade Activity.
Equity Detail
Adjusted Tax Cost Unrealized Est Annual Inc
Price Quantity Value Original Cost Gain.toss Accrued Div. Yield
US Large Cap Equity
ABBOTT LABORATORIES 54.15 148.000 8,014.20 7,308.74 705.48 284.16 3.55%
002824-10-0 AST 71.04
ANALOG DEVICES INC 39.13 176.000 6,886.88 8,011.39 875.49 176.00 2.56%
032854-10-5 ADI
JP Morgan Page 4 of 11
Confidential Treatment Requested by JPMorgan JPM-SDNY-00049623
Chase
CONFIDENTIAL SDNY_GM_00318821
EFTA01522138